ABBOTT LABORATORIES — Net Income by Fiscal Year
15 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/dcbd4362-eed9-4b57-871e-e9917229acdc/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $6.5B | 2025-01-01 – 2025-12-31 | evidence 0001628280-26-010185 |
| FY 2024 | $13.4B | 2024-01-01 – 2024-12-31 | evidence 0001628280-25-007110 |
| FY 2023 | $5.7B | 2023-01-01 – 2023-12-31 | evidence 0001628280-24-005348 |
| FY 2022 | $6.9B | 2022-01-01 – 2022-12-31 | evidence 0001628280-23-004026 |
| FY 2021 | $7.1B | 2021-01-01 – 2021-12-31 | evidence 0001104659-22-025141 |
| FY 2020 | $4.5B | 2020-01-01 – 2020-12-31 | evidence 0001104659-21-025751 |
| FY 2019 | $3.7B | 2019-01-01 – 2019-12-31 | evidence 0001104659-20-023904 |
| FY 2018 | $2.4B | 2018-01-01 – 2018-12-31 | evidence 0001047469-19-000624 |
| FY 2017 | $477.0M | 2017-01-01 – 2017-12-31 | evidence 0001047469-18-000856 |
| FY 2016 | $1.4B | 2016-01-01 – 2016-12-31 | evidence 0001047469-17-000744 |
| FY 2015 | $4.4B | 2015-01-01 – 2015-12-31 | evidence 0001047469-16-010246 |
| FY 2014 | $2.3B | 2014-01-01 – 2014-12-31 | evidence 0001047469-15-001377 |
| FY 2013 | $2.6B | 2013-01-01 – 2013-12-31 | evidence 0001047469-14-001176 |
| FY 2012 | $6.0B | 2012-01-01 – 2012-12-31 | evidence 0001047469-14-001176 |
| FY 2011 | $4.7B | 2011-01-01 – 2011-12-31 | evidence 0001047469-14-001176 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
ABBOTT LABORATORIES — all facts · Revenue · Operating Income